Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term outcomes from sepsis.

Sachin Yende1, Derek C Angus

  • 1Department of Critical Care Medicine, University of Pittsburgh, 642A Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA. yendes@upmc.edu

Current Infectious Disease Reports
|September 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients.

Critical care medicine·2023
Same author

Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use.

BMC infectious diseases·2023
Same author

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

JAMA·2022
Same author

Invited commentary on Sepsis.

Surgery·2022
Same author

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.

Open forum infectious diseases·2022
Same author

Proteomic changes associated with racial background and sepsis survival outcomes.

Molecular omics·2022
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Severe sepsis survivors face high long-term mortality, with innate immune system dysfunction potentially driving poor outcomes. Understanding these mechanisms is crucial for improving survival after critical illness.

Area of Science:

  • Critical care medicine
  • Immunology
  • Epidemiology

Background:

  • Severe sepsis is associated with significant long-term mortality, with less than 50% of patients surviving one year.
  • The underlying mechanisms contributing to this increased long-term mortality are not well understood.
  • Emerging evidence suggests innate immune system dysregulation may play a role.

Purpose of the Study:

  • To review the epidemiology of long-term mortality after severe sepsis.
  • To explore potential mechanisms, particularly innate immune system abnormalities, contributing to poor long-term outcomes.
  • To discuss the challenges in studying long-term outcomes in critically ill patients.

Main Methods:

  • Literature review of animal and human studies.

Related Experiment Videos

  • Examination of epidemiological data on sepsis survivors.
  • Analysis of proposed immunological mechanisms.

    • Main Results:

    • Long-term mortality after severe sepsis remains a significant clinical problem.
    • Innate immune system dysfunction is a plausible contributor to persistent morbidity and mortality.
    • Conducting rigorous long-term studies in this population presents unique methodological hurdles.

    Conclusions:

    • Further research is needed to elucidate the precise mechanisms linking sepsis to long-term mortality.
    • Targeting immune system abnormalities may offer future therapeutic strategies.
    • Improved study designs are required to better understand sepsis's long-term impact.